Maximizing Bioavailability. Minimizing Timeline.
We’re not just a lab. Or a consultant. Or another pair of hands.
We’re a boutique development partner with decades of experience and a passion for helping you take your drugs into the clinic — and the market — as quickly as possible.
How We Can Help
Our CMC services are intentionally narrow to let us concentrate
our resources and expertise on solving your specific problems.
Deep expertise. Intelligent solutions.
The team at Nucleo is small, but mighty, with decades of experience turning innovative therapies into commercially viable products. In fact, we’ve been involved in six successful drug approvals and look forward to working alongside your teams to get your drug to trial and market as quickly and efficiently as possible.
MARK MENNING, PhD
Mark Menning has almost two decades of pharmaceutical development experience in scientific and management roles at Actera Pharmaceuticals, Tobira Therapeutics, Gilead Sciences, Amgen, and DuPont Pharmaceuticals. He led the formulation/ process development and participated in NDA authoring of multiple fixed-dose combination products for the treatment of HIV/AIDS and is a co-inventor of Truvada®, Atripla®, Complera®, Stribild®, Vitekta™, and Tybost™ tablets.
LARA PARK MENNING, MSc
Director of Operations
Lara has over a decade of pharmaceutical industry experience in global project management at Roche/Genentech, Patheon in Canada and Laboratoires Pierre Fabre in France. As a Project Management Professional (PMP), she most recently she acted as Operations and Project Management Manager at Actera Pharmaceuticals.
Nucleo Life Sciences • 27 Jordan St., Suite B • San Rafael, CA 94901 • (415) 619-7206